LIPOCINE INC. Increase (Decrease) in Accounts Receivable
LIPOCINE INC. (LPCN) reported Increase (Decrease) in Accounts Receivable of $0 for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2014-08-13
- LIPOCINE INC. increase (decrease) in accounts receivable for the quarter ending 2014-06-30 was $0.00.
- LIPOCINE INC. increase (decrease) in accounts receivable for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. increase (decrease) in accounts receivable for the quarter ending 2013-12-31 was $0.00.
- LIPOCINE INC. increase (decrease) in accounts receivable for the quarter ending 2013-09-30 was -$92.73K.
- LIPOCINE INC. increase (decrease) in accounts receivable for fiscal 2013 was $0.00.
- LIPOCINE INC. increase (decrease) in accounts receivable for fiscal 2012 was -$313.75K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $0.00 10-Q · filed 2014-08-13 | $0.00 derived: sum of 3 quarters · filed 2014-08-13 | -$92.73K derived: sum of 4 quarters · filed 2014-08-13 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-13 | $0.00 derived: sum of 2 quarters · filed 2014-05-13 | -$92.73K derived: sum of 3 quarters · filed 2014-05-13 | -$375.62K derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$92.73K derived: sum of 2 quarters · filed 2014-03-31 | -$375.62K derived: sum of 3 quarters · filed 2014-08-13 | $0.00 10-K · filed 2014-03-31 |
| 2013-09-30 | -$92.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$375.62K derived: sum of 2 quarters · filed 2014-08-13 | $0.00 10-Q · filed 2013-11-13 | -$22.55K derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-06-30 | -$282.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $92.73K 10-Q · filed 2014-08-13 | $70.18K derived: sum of 3 quarters · filed 2014-08-13 | |
| 2013-03-31 | $375.62K 10-Q · filed 2014-05-13 | $353.06K derived: sum of 2 quarters · filed 2014-05-13 | ||
| 2012-12-31 | -$22.55K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$313.75K 10-K · filed 2014-03-31 | ||
| 2012-09-30 | -$291.20K 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |